Publication:
Oxidized-LDL and Fe3+/Ascorbic Acid-Induced Oxidative Modifications and Phosphatidylserine Exposure in Human Platelets are Reduced by Melatonin

dc.contributor.authorsSener, A.; Ozsavci, D.; Bingol-Ozakpinar, O.; Cevik, O.; Yanikkaya-Demirel, G.; Yardimci, T.
dc.date.accessioned2022-03-12T17:37:22Z
dc.date.accessioned2026-01-10T17:56:33Z
dc.date.available2022-03-12T17:37:22Z
dc.date.issued2009
dc.description.abstractLow-density lipoprotein (LDL) modifications and platelet activation are major risk factors for cardiovascular diseases. When platelets are exposed to oxidative stress, they become activated. Oxidized LDL (ox-LDL) and metal-catalysed oxidation systems such as Fe3+/ascorbic acid increase free radical production. We wanted to verify whether melatonin has a protective effect against oxidative modifications and phosphatidylserine externalization in platelets induced by ox-LDL and Fe3+/ascorbic acid. For in vitro effects of melatonin on platelets, ADP-activated platelets were incubated with ox-LDL or Fe3+/ascorbic acid for 1 h at 37 degrees C with or without melatonin. Then platelet malondialdehyde, protein carbonyl and glutathione levels were measured. Platelet phosphatidylserine exposure was measured with annexin-V using flow cytometry. Malondialdehyde, protein carbonyl and phosphatidylserine levels of platelets treated with Fe3+/ascorbic acid significantly increased compared to the control group. Glutathione contents of Fe3+/ascorbic acid-treated platelets significantly decreased. Melatonin pre-treatment of Fe3+/ascorbic acid-treated platelets caused a marked reduction in malondialdehyde anti phosphatidylserine levels and a marked increase in glutathione levels. Melatonin also caused non-significant reduction in protein carbonyl contents of Fe3+/ascorbic acid-treated platelets. Malondialdehyde, protein carbonyl and phosphatidylserine levels of platelets treated with ox-LDL also significantly increased compared to the control group. Platelet glutathione levels non-significantly decreased with ox-LDL. With addition of melatonin, malondialdehyde, protein carbonyl and phosphatidylserine levels of platelets treated with ox-LDL significantly decreased. These data suggest that melatonin May protect platelets from iron overload-induced and ox-LDL-induced oxidative modifications and also from the triggering signals of apoptosis activation, possibly due to its scavenger effect on toxic free radicals.
dc.identifier.doidoiWOS:000265765100003
dc.identifier.issn0015-5500
dc.identifier.pubmed19454178
dc.identifier.urihttps://hdl.handle.net/11424/229372
dc.identifier.wosWOS:000265765100003
dc.language.isoeng
dc.publisherCHARLES UNIV PRAGUE, FIRST FACULTY MEDICINE
dc.relation.ispartofFOLIA BIOLOGICA
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectmelatonin
dc.subjectox-LDL
dc.subjectoxidative modifications
dc.subjectiron
dc.subjectascorbic acid
dc.subjectphosphatidylserine
dc.subjectplatelet
dc.subjectHYDROXYL RADICAL FORMATION
dc.subjectLOW-DENSITY-LIPOPROTEIN
dc.subjectLIPID-PEROXIDATION
dc.subjectGLUTATHIONE DEPLETION
dc.subjectCELL-DEATH
dc.subjectAPOPTOSIS
dc.subjectACTIVATION
dc.subjectIRON
dc.subjectAGGREGATION
dc.subjectABSENCE
dc.titleOxidized-LDL and Fe3+/Ascorbic Acid-Induced Oxidative Modifications and Phosphatidylserine Exposure in Human Platelets are Reduced by Melatonin
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage52
oaire.citation.issue2
oaire.citation.startPage45
oaire.citation.titleFOLIA BIOLOGICA
oaire.citation.volume55

Files